PillRx only · Injection · Subarachnoid
Bupivacaine Hydrochloride
Bupivacaine Hydrochloride
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
13
Rx · 2025 Q2
10
Units dispensed
2
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Brookfield Pharmaceuticals, LLC. | unknown | 2 | SUPPLYING |
| Huons Co., Ltd. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 2, 2026RECALLRecall (Class II): Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufacture…
Lack of Assurance of Sterility — Recalling firm: Huons Co., Ltd. — USA Nationwide.
- Feb 20, 2018SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Huons Co., Ltd)
Bupivacaine Hydrochloride Injection — reported in shortage by Huons Co., Ltd. Therapeutic category: Anesthesia.